سعر ابيزيثرو 200 مجم/5 مل 30 مل 2025

Azithromycin 200 mg/5 ml powder for oral suspension, 30 ml bottle (EIPICO Epizithro).

• Directory: broad-spectrum antibiotic used to treat many infections
• Mild to moderate infections caused by susceptible bacteria in adults: acute bacterial exacerbations of COPD, acute bacterial sinusitis, community-acquired pneumonia, pharyngitis/tonsillitis, uncomplicated skin and skin-structure infections, urethritis and cervicitis, genital ulcer disease (chancroid) in men.Population: AdultsDailyMed (U.S. NLM)
• Pediatric patients: acute otitis media and community-acquired pneumonia (6 months and older); pharyngitis/tonsillitis (2 years and older).Population: Pediatric patients >=6 monthsDailyMed (U.S. NLM)

• Most common: diarrhea (5-14%), nausea (3-18%), abdominal pain (3-7%) and vomiting.International label, equivalent formulation · DailyMed (U.S. NLM)

• Known hypersensitivity to azithromycin, erythromycin, any macrolide or ketolide; history of cholestatic jaundice/hepatic dysfunction associated with prior azithromycin use.International label, equivalent formulation · DailyMed (U.S. NLM)

• Serious (including fatal) allergic and skin reactions can occur; discontinue if a reaction occurs.International label, equivalent formulation · DailyMed (U.S. NLM)
• Severe, sometimes fatal hepatotoxicity has been reported; discontinue immediately if signs of hepatitis occur.International label, equivalent formulation · DailyMed (U.S. NLM)
• QT prolongation and torsades de pointes have been reported; consider the risk in patients with known QT prolongation, proarrhythmic conditions or other QT-prolonging drugs. Observational studies suggest a short-term increase in cardiovascular death.International label, equivalent formulation · DailyMed (U.S. NLM)

• Warfarin (oral anticoagulants)May potentiate anticoagulant effect; monitor prothrombin time carefully.DailyMed (U.S. NLM)
• NelfinavirIncreases azithromycin concentrations; monitor for liver enzyme abnormalities and hearing impairment.DailyMed (U.S. NLM)

• Decades of published data and postmarketing experience have not identified a drug-associated risk of major birth defects, miscarriage or adverse maternal or fetal outcomes.International label, equivalent formulation · DailyMed (U.S. NLM)
• Azithromycin is present in human milk; non-serious adverse reactions have been reported in breastfed infants. Monitor the infant for diarrhea, vomiting or rash.International label, equivalent formulation · DailyMed (U.S. NLM)

• Azithromycin: Macrolide antibacterial; binds the 50S ribosomal subunit and inhibits bacterial protein synthesis (Zithromax USPI).